Who
Atul Kavthekar
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, LifeMD; Chief Financial Officer, P3 Health Partners; Chief Financial Officer, Diplomat Pharmacy.
In numbers
- Trades disclosed
- 12
- Buys
- 2
- Sells
- 2
- Bought
- $80K
- Sold
- $13K
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 1 May 2017
- Last trade
- 11 May 2026
- Last filed
- 13 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 May 2026filed 13 May 2026 | LFMD LifeMDDigital Health & Telemedicine | SEC FORM 4 Code A | —337,500 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | LFMD LifeMDDigital Health & Telemedicine | SEC FORM 4 Code A | —337,500 at $0.00 | filing |
| 2 Aug 2023filed 1 Sep 2023 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 15 May 2023filed 16 May 2023 | PIII P3 Health PartnersProviders & Facilities | SEC FORM 4 Bought | $50K18,868 at $2.65 | filing |
| 12 Dec 2022filed 14 Dec 2022 | PIII P3 Health Partnersoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 29 Mar 2019filed 1 Apr 2019 | Diplomat Pharmacy | SEC FORM 4 Sold | $5,244901 at $5.82 | filing |
| 19 Mar 2019filed 20 Mar 2019 | Diplomat Pharmacy | SEC FORM 4 Sold | $7,3881,265 at $5.84 | filing |
| 18 Mar 2019filed 20 Mar 2019 | Diplomat Pharmacy | SEC FORM 4 Code A | —15,118 at $0.00 | filing |
| 27 Mar 2018filed 29 Mar 2018 | Diplomat Pharmacy | SEC FORM 4 Code A | —11,100 at $0.00 | filing |
| 27 Mar 2018filed 29 Mar 2018 | Diplomat Pharmacyoption or derivative | SEC FORM 4 Code A | —26,384 at $0.00 | filing |
| 20 Nov 2017filed 20 Nov 2017 | Diplomat Pharmacy | SEC FORM 4 Bought | $30K2,000 at $15.00 | filing |
| 1 May 2017filed 2 May 2017 | Diplomat Pharmacyoption or derivative | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.